Tag Archives: COVID-19

Financial Literacy and COVID-19 | Charles Schwab Foundation

Posted on by

“89 percent of respondents to a Charles Schwab’s survey believe a lack of financial literacy contributes to larger social issues—from poverty, to fewer job opportunities, to wealth and gender inequality.” Carrie Schwab-Pomerantz

  • Even in the wake of a global health crisis, Americans value financial education.
  • An overwhelming majority of Americans believe that a lack of financial literacy contributes to larger social issues.
  • Americans want our schools to take the lead in providing our youth with a financial education.

The impact of financial illiteracy is not lost on the American public. 89% of Americans agree that lack of financial education contributes to some of the biggest social issues our country faces, including poverty (58%), lack of job opportunities (53%), unemployment (53%), and wealth inequality (52%).

“Financial illiteracy is insidious. The antidote is financial education, which gives people the skills they need to make smart money decision and can help improve their lives.” Carrie Schwab-Pomerantz, president of Charles Schwab Foundation.

Americans indicated they wish they had better money management skills, according to a Charles Schwab survey. When asked what they would teach their younger selves about personal finance based on what they know today, Americans said the value of saving money (59%), basic money management (52%), and how to set financial goals and work toward them (51%).

From the survey, it is apparent that every person in America should be taught the fundamentals of money management including budgeting, saving, avoiding debt, setting financial goals and investing.

“The pandemic has underscored just how critical basic personal finance skills are in preparing for the unexpected. Financial literacy is a survival skill that everyone needs.” Carrie Schwab-Pomerantz

Carrie Schwab-Pomerantz recommends five key steps every American can take to help shore up their finances during this period of global health crisis and economic uncertainty.

  • Start an emergency fund (or add more to it) to help protect yourself against an unexpected drop in income or expense shock. Set aside whatever you can – every little bit counts. Try to aim for $1,000-$2,000 to get started, and then work your way up to 3-6 month worth of essential expenses over time.
  • Create a budget to help you prioritize and assess your financial resources. Self-isolation has led to different spending patterns for many people, including cutting back on what we may have previously thought of as “essential.”
  • Create a financial plan to help you navigate from where you are to where you want to be. You don’t need to have a lot of money to need a financial plan. Consider it a roadmap to reach your financial goals, whether that’s to pay off debt, build savings, or make a large purchase.
  • Ask for help if you’re struggling. Given the scale of this economic crisis, the government, lenders and creditors are trying to work with borrowers through this difficult time. Don’t hide from creditors – that can make things worse.
  • Focus on what you can control. You can’t predict or control the market, but you can control how you manage your investments, your savings rate, having a financial plan and how you react to events.

“The need for financial literacy is especially urgent for women and minorities, who continue to face unique challenges at home and in the workplace,” said Schwab-Pomerantz.

However, financial literacy isn’t a cure-all, but it is an essential key to unlocking doors to opportunity and financial security.

References:

  1. https://www.schwab.com/resource-center/insights/content/americans-want-financial-literacy-now?SM=URO#sf237483690
  2. https://pressroom.aboutschwab.com/press-releases/press-release/2020/Charles-Schwab-Financial-Literacy-Survey-Exposes-Grave-Impact-of-Lack-of-Financial-Education-During-COVID-19/default.aspx

Melatonin and COVID-19

Posted on by

Researchers at the Cleveland Clinic, using AI, found that those who regularly took the sleep hormone melatonin were about 28 percent less likely to test positive for COVID—with Black patients showing an even greater reduced likelihood of 52 percent.

Through the use of artificial intelligence, results from a Cleveland Clinic led study suggests that melatonin, a hormone that regulates the sleep-wake cycle and is commonly used as a sleep aid, may be a viable treatment option for COVID-19.

Melatonin supplements are commonly recommended by many health professionals to help induce sleep, according the the Cleveland Clinic. Research has found that taking melatonin in low doses is the most effective way to promote sleep if you are experiencing restlessness, sleeplessness or insomnia.

Melatonin naturally produced by our bodies

The hormone serotonin (which regulates mood, appetite and memory) is produced during the day and this changes to melatonin when it gets dark outside, Cleveland Clinic reports. Peak levels of melatonin are produced before 3 a.m., when it sharply decreases before natural daylight returns.

Researchers at the Cleveland Clinic were able to sort through data on over 27,000 patients in a COVID-19 registry to find any commonalities. Interestingly, results showed that those who regularly took melatonin were about 28 percent less likely to test positive for COVID—with Black patients showing an even greater reduced likelihood of 52 percent.

Researchers admit that they don’t entirely understand what “exact mechanisms” about melatonin provide extra protection against COVID, including whether or not it’s because patients are sleeping better, longer hours, the New York Post reports.

Some studies have shown that melatonin can reduce chronic and acute inflammation. And, a recent study from the University of Toronto published in the journal Diseases found that melatonin could help boost the efficacy of the coronavirus vaccine, calling it a potential “silver bullet” in the fight against the pandemic.

Health experts know that the coronavirus can trigger “a massive inflammatory reaction,” also known as a “cytokine storm,” in the body that can lead to permanent tissue damage, heart injury, acute respiratory distress syndrome (ARDS), organ failure and death, according to a study published in the journal Frontiers in Medicine.

Melatonin can control and reverse this immune response, suggesting it may have beneficial effects in preventing or reducing the inflammation overload.

Short-term use of melatonin has relatively few side effects and is well-tolerated by the majority of people who take it, according to the Sleep Foundation. The most commonly reported side effects are daytime drowsiness, headaches, and dizziness, but these are experienced by only a small percentage of people who take melatonin.

References:

  1. https://consultqd.clevelandclinic.org/melatonin-a-promising-candidate-for-prevention-and-treatment-of-covid-19/
  2. https://health.clevelandclinic.org/melatonin-how-much-should-i-take-for-a-good-nights-rest/#:~:text=It%20is%20sold%20over%20the%20counter%20in%20a,Advertising%20on%20our%20site%20helps%20support%20our%20mission.
  3. https://bestlifeonline.com/melatonin-covid/
  4. https://nypost.com/2020/12/29/scientists-study-melatonin-as-possible-covid-19-treatment/amp/?__twitter_impression=true
  5. https://www.miamiherald.com/news/coronavirus/article248150170.html
  6. https://www.sleepfoundation.org/melatonin

Receiving the COVID-19 Vaccine

Posted on by

As fatiguing as 2020 and the COVID-19 pandemic have been, science has stepped up this year to provide humankind with a pair of truly hopeful gifts: the first two FDA approved COVID-19 vaccines.

Two weeks ago, the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) to a COVID-19 vaccine from Pfizer/BioNTech, enabling distribution to begin to certain high-risk groups just three days later.

More recently, the FDA granted an EUA to a COVID-19 vaccine from the biotechnology company Moderna, Cambridge, MA. This messenger RNA (mRNA) vaccine, which is part of a new approach to vaccination, was co-developed by NIH’s National Institute of Allergy and Infectious Diseases (NIAID).

The EUA of the Moderna vaccine is based on data showing the vaccine is safe and 94.5 percent effective at protecting people from infection with SARS-CoV-2, the coronavirus that causes COVID-19.

Messenger-RNA vaccines are safe

The two vaccines currently authorized for EUA in the United States work in a unique way. Their centerpiece is a small, non-infectious snippet of mRNA. Our cells constantly produce thousands of mRNAs, which provide the instructions needed to make proteins. When someone receives an mRNA vaccine for COVID-19, it tells the person’s own cells to make the SARS-CoV-2 spike protein, according to information provided by the National Institute of Allergy and Infectious Diseases (NIAID). The person’s immune system then recognizes the viral spike protein as foreign and produces antibodies to eliminate it.

This vaccine-spurred encounter trains the human immune system to remember the spike protein. So, if an actual SARS-CoV-2 virus tries to infect a vaccinated person weeks or months later, his or her immune system will be ready to fend it off. To produce the most vigorous and durable immunity against the virus, people will need to get two shots of mRNA vaccine, which are spaced several weeks to a month apart, depending on the vaccine.

Some misinformed individuals (or trolls) have raised concerns on social media that mRNA vaccines might alter the DNA genome of someone being vaccinated. But that’s not possible, since this mRNA doesn’t enter the nucleus of the cell where DNA is located. Instead, the vaccine mRNAs stay in the outer part of the cell (the cytoplasm).

NIAID Director Dr. Anthony Fauci received Moderna’s COVID19 vaccine, co-developed with NIH. It’s imperative that you roll up your sleeve and accept the potentially life-saving gift of a COVID-19 vaccine. Accepting this gift is your best chance to put this pandemic behind you and your family, as we look forward to a better new year.

Vaccines are the best hope for the nation to overcome the COVID-19 pandemic, public surveys indicate that some people are uneasy about accepting this disease-preventing vaccine. Some have even indicated they will refuse to take the vaccine. Healthy skepticism is a good thing, but decisions like this ought to be based on weighing the evidence of benefit versus risk.

The results of the Pfizer and Moderna trials, all released for complete public scrutiny, indicate the potential benefits are high and the risks, low. Despite the impressive speed at which the new COVID-19 vaccines were developed, they have undergone and continue to undergo a rigorous process to generate all the data needed by the FDA to determine their long-term safety and effectiveness.

Unfortunately, the gift of COVID-19 vaccines comes too late for the more than 313,000 Americans who have died from complications of COVID-19, and many others who’ve had their lives disrupted and may have to contend with long-term health consequences related to COVID-19. The vaccines did arrive in record time, but all of us wish they could somehow have arrived even sooner to avert such widespread suffering and heartbreak.

It will be many months before all Americans who are willing to get a vaccine can be immunized. We need 75-80 percent of Americans to receive vaccines in order to attain the so-called “herd immunity” needed to drive SARS-CoV-2 away and allow us all to get back to a semblance of normal personal and professional life.

References:

  1. https://directorsblog.nih.gov/2020/12/22/celebrating-the-gift-of-covid-19-vaccines/

Top Five Global Investment Risks In 2021 | Charles Schwab

Posted on by

The top five global risks for investors in 2021 are all surprises to the consensus view:

  • Problems with the vaccine rollout,
  • Geopolitical and trade tensions do not subside,
  • Fiscal and/or monetary policy tightens,
  • A “zombie” economy, and
  • Interest rate/dollar shock.

History demonstrates that the biggest financial risks in a typical year aren’t usually from out of left field (although a black swan did occur in 2020 with the COVID-19 outbreak). Rather, they are often hiding in plain sight.

Risk appears when there is a very high degree of confidence among market participants in a specific outcome that doesn’t pan out. So, by identifying the unexpected, here are the top five downside global risks for investors in 2021. To read more: https://www.schwab.com/resource-center/insights/content/top-five-global-investment-risks-2021?cmp=em-QYD

Be prepared

Whether or not these particular risks come to pass, a new year almost always brings surprises of one form or another. Having a well-balanced, diversified portfolio and being prepared with a plan in the event of an unexpected outcome are keys to successful investing.

References:

  1. https://www.schwab.com/resource-center/insights/content/top-five-global-investment-risks-2021?cmp=em-QYD

African Americans Disproportionately Dying

Posted on by

African Americans are dying from the coronavirus at almost 3 times the rate of their white counterparts.

Black and Hispanic Americans were disproportionately more likely to die of COVID-19 during the spring and summer months indicating that the coronavirus’s toll is falling most heavily on underserved and minority communities, according to the Centers for Disease Control and Prevention (CDC).

When you consider that African Americans represent 12.5 percent of the population, but account for almost 23 percent of all coronavirus deaths, the COVID-19 pandemic is disproportionately decimating the black working class communities across the country.

Coronavirus has become the third leading cause of death of citizens in the United States in calendar year 2020. The virus has killed more than 300,000 since arriving on U.S. shores, making it a leading cause of death after heart disease and cancer.

In 2018, the 10 leading causes of death for all Americans (heart disease, cancer, unintentional injuries, chronic lower respiratory diseases, stroke, Alzheimer disease, diabetes, influenza and pneumonia, kidney disease, and suicide) remained the same as in 2017. The 10 leading causes accounted for 73.8% of all deaths in the United States in 2018.

The Centers for Disease Control and Prevention (CDC) maintains a provisional death count related to COVID-19. The deaths counted in that data are well below those compiled from the state and county levels because the provisional count is based on death certificates that may take weeks to filter up to the federal agency.

With respect to controlling the pandemic, Martin Luther King Jr. once declared “Whatever affects one directly, affects all indirectly.” This is definitely true for epidemiology and controlling the pandemic. To protect the health of all us, we must insure the health of the most vulnerable among us.

How to control COVID-19 is not a mystery — it requires wearing masks, social physical distancing of 6 feet, frequent washing of hands, widespread contact tracing and COVID testing and widespread vaccination. However, these efforts to combat the pandemic require people to trust the science and those behind the public health measures.

In the nationwide fight against the COVID-19 pandemic, well founded mistrust has developed over decades by African Americans of the government, public health officials and ‘the science’ can and has killed a disproportionate share of working class Blacks and other people of color.

References:

  1. https://www.cdc.gov/nchs/nvss/vsrr/covid19/
  2. https://www.usatoday.com/story/opinion/2020/09/09/covid-19-disproportionate-effect-african-americans-and-how-control-column/5679676002/
  3. https://www.cdc.gov/nchs/nvss/vsrr/covid19/tech_notes.htm

Masks Protect Those Around You

Posted on by

Image

COVID-19 spreads mainly from person to person through respiratory droplets. Respiratory droplets travel into the air when you cough, sneeze, talk, shout, or sing. These droplets can then land in the mouths or noses of people who are near you or they may breathe these droplets in.

Masks are a simple barrier to help prevent your respiratory droplets from reaching others. Studies show that masks reduce the spray of droplets when worn over the nose and mouth.

woman wearing face covering, with a detail showing how the cloth barrier helps to contain respiratory droplets that she exhales

You should wear a mask, even if you do not feel sick. This is because several studies have found that people with COVID-19 who never develop symptoms (asymptomatic) and those who are not yet showing symptoms (pre-symptomatic) can still spread the virus to other people. The main function of wearing a mask is to protect those around you, in case you are infected but not showing symptoms.

It is especially important to wear a mask when you are unable to stay at least 6 feet apart from others since COVID-19 spreads mainly among people who are in close contact with one another (within about 6 feet).

Your mask offers some protection to you

A cloth mask also offers some protection to you too. How well it protects you from breathing in the virus likely depends on the fabrics used and how your mask is made (e.g. the type of fabric, the number of layers of fabric, how well the mask fits). CDC is currently studying these factors.

Who should or should not wear a mask

CDC guidance is that everyone 2 years of age and older should wear a mask in public settings and when they are around people who do not live in their household.  However, according to CDC, masks should not be worn by:

  • Children younger than 2 years old
  • Anyone who has trouble breathing
  • Anyone who is unconscious, incapacitated or otherwise unable to remove the mask without assistance
  • Wearing masks may be difficult for some people with sensory, cognitive, or behavioral issues. If they are unable to wear a mask properly or cannot tolerate a mask, they should not wear one,

https://youtu.be/dSvff0QljHQ

Key Takeaways:

  • People age 2 and older should wear masks in public settings and when around people who don’t live in their household.
  • Masks offer some protection to you and are also meant to protect those around you, in case you are unknowingly infected with the virus that causes COVID-19.
  • A mask is NOT a substitute for social distancing. Masks should still be worn in addition to staying at least 6 feet apart.
  • Wash your hands with soap and water for at least 20 seconds or use hand sanitizer with at least 60% alcohol after touching or removing your mask.
  • Postponing holiday travel & staying home is the best way to protect yourself & others from COVID19. If you decide to travel internationally, check out CDC’s testing recommendations to help make travel safer. 
  • Masks may not be necessary when you are outside by yourself away from others, or with other people who live in your household. However, some localities may have mask mandates while out in public and these mandates should always be followed.

References:

  1. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cloth-face-cover-guidance.html

Vaccination and Wearing Masks

Posted on by

“Once enough people have some immunity, either because of previous infection or because of vaccination, the virus will have a hard time spreading through the community.” Consumer Reports

Researchers hope that Americans getting vaccination will be sufficient to end the pandemic once there is sufficient supply and enough pf the population gets vaccinated.

In trying to understand the readily available vaccine information and how it will affect the lives of Americans, Consumer Reports has reviewed government guidance and consulted with public health experts to provide insight to their readers about the vaccine candidates.

Vaccination equals two doses

Vaccines require two doses—an initial shot and a booster, taken several weeks later. Generally with a two-dose vaccine, it takes about two weeks from the second dose for a vaccine’s protection to fully kick in, according to Natalie Dean, PhD, an assistant professor of biostatistics specializing in infectious disease and vaccine development at the University of Florida.

Though two doses are necessary, the FDA’s analysis of the Pfizer vaccine indicates that people appear to be somewhat less likely to get COVID-19 within two weeks of receiving the first dose.

It’s unclear how long protection from that first dose may last. And the second dose is still required for full protection, to ensure a more durable immune response. 

Halting the virus transmission

It is not known definitely whether getting vaccinated will prevent you from spreading the coronavirus to others. Thus, preventive measures such as social distancing, washing hands, and wearing a mask will remain important even after you get vaccinated, according to the CDC.

More research is required before scientists can say exactly how many people need to be vaccinated to achieve “herd immunity “. It’s possible that with extremely effective vaccines showing 95 percent efficacy, we might hit the point where communities are protected by the time somewhere between 60 and 70 percent of people have been vaccinated, according to Kathleen Neuzil, MD, a professor of vaccinology and director of the Center for Vaccine Development and Global Health at the University of Maryland in Baltimore. 

It will be possible for vaccines, as long as Americans get vaccinated, to have a significant impact on ending this pandemic.

Severe allergic reactions

In the U.K., public health regulators have advised that anyone with a history of a severe, potentially life-threatening allergic reaction to a vaccine, medicine, or food should not receive the vaccine. Two healthcare workers were reported to have had severe allergic reactions after receiving the vaccine. Public health experts worry that the reports could frighten people with allergies and make them think they should avoid getting the vaccine.

From Pfizer’s vaccine trial results, there were no severe allergic reactions. Deliberately, the trials excluded people who had previously had severe allergic reactions to vaccines, a Pfizer scientist said during the advisory panel’s discussion.

The FDA plans to advise that people who are allergic to components of the vaccine should not get it, an agency scientist explained. The FDA’s earlier review of Pfizer’s trial data found slightly more potential minor allergic reactions in the group that received the vaccine than in the placebo group, but none of these were severe, and none occurred immediately after people received their doses of vaccine.

References:

  1. https://www.consumerreports.org/vaccines/your-questions-about-a-coronavirus-vaccine-answered/?EXKEY=YSOCIAL_FB&fbclid=IwAR2LW6PC_JSykJwyG-Kv9ozQkNvxH-1VnYmAby-MJIr8kSJfHm7UwtyH3k8

Vitamin D: Powerful Protection vs. Viruses

Posted on by

A new study from Spain looked at 216 hospital patients with COVID-19 and found that 80 percent didn’t have adequate levels of vitamin D in their blood, according to Healthline.com.

Recent research discovered a correlation between vitamin D deficiency and a higher risk of COVID-19. Now, another new study has found the same — noting that more than 80 percent of people with COVID-19 didn’t have adequate levels of the “sunshine vitamin” in their blood.  “It looks like patients with a poor vitamin D status may have more severe COVID-19,” said Dr. Hans Konrad Biesalski, a professor at the University of Hohenheim who has evaluated vitamin D and COVID-19..

Vitamin D is a potent weapon against viruses and crucial for immune health — make sure you’re getting enough

There appears to be strong evidence that Vitamin D plays a critical role for your body’s immune system and can ward off respiratory infections. Vitamin D does not effect the viruses, but effects the way our immune system handles infections including viruses.

Boosting your immune system is one of the best things you can do because it is your body’s key defense when it comes to fighting a virus. Even if you are exposed to a virus and if your immune system is strong, you have a better chance of not getting sick.

A major 2017 study published in the British Medical Journal looked at vitamin D’s effectiveness against viral infections. Researchers analyzed 25 clinical trials that included 11,321 people. The data came from 14 countries, including the U.S., England, Japan, Australia, Canada, and Italy.

The study found that taking vitamin D supplements cuts in half the risk of respiratory infections caused by viruses.[1]

Many people recommend that people at high risk for COVID-19 — older adults, those with underlying conditions, and people in nursing homes — can be treated with vitamin D.  “Vitamin D treatment should be recommended in COVID-19 patients with low levels of vitamin D circulating in the blood since this approach might have beneficial effects in both the musculoskeletal and the immune system,” Hernández said in a statement.

Many Americans have a vitamin D deficiency

Vitamin D supplements should be considered one of the many tools that might help when conventional therapies are not enough. Research has found that vitamin D improves viral immunity by strengthening your mucus membranes.

Vitamin D is a key nutrient for your immune system. Once thought as the vitamin for strong bones, vitamin D actually does a lot more for your body — including support your immune system.

The coronavirus and other viruses get into your body through entry points that are covered with mucus membranes. They include your nose, mouth, eyelids, lungs, trachea (windpipe).

A lab study at the University of Illinois found that vitamin D helps mucus membranes provide a stronger barrier to viruses by increasing the antimicrobial compounds in them.

With coronavirus pandemic, researchers have not yet had time to fully test vitamin D directly against it. But they say there’s no reason to think that it would not work just as well against coronavirus as it does against the flu, colds, and other upper respiratory viruses.  “Very low vitamin D status has lots of negative consequences and this could be the case for COVID-19, but that’s not the same as saying that routine vitamin D supplementation will prevent severe infection,” he told Healthline.

  1. https://www.healthline.com/health-news/new-study-found-80-percent-of-covid-19-patients-were-vitamin-d-deficient
  2. https://www.bmj.com/content/356/bmj.i6583
  3. https://www.institutefornaturalhealing.com/2020/03/coronavirus-one-vitamin-may-be-the-key-to-stopping-it/
  4. https://www.bing.com/amp/s/www.cnet.com/google-amp/news/the-surprising-role-vitamin-d-plays-in-your-immune-health/

Coaches Voice Stopping College Basketball Season

Posted on by

Stop the season. Stop the games, men’s and women’s college basketball, right now, according to several prominent college basketball coaches.

The college basketball season officially began in late November — yet, 33 men’s teams still have not played one game because of COVID-19 interruptions. A number of prominent voices in the college basketball game are wondering if the season should be stopped or postponed with the COVID-19 crisis anything but under control, especially with the physical, emotional and mental toll it has on college student athletes.

Many states has declared the coronavirus outbreak a public health emergency and have implemented restrictions on travel, business and public gatherings. Additionally, there are approximately 2,000 deaths a day and nearly 300,000 new COVID-19 infection cases daily across the country. Nationally and locally, communities have experienced a spike in positive COVID-19 cases since late November. Local and state governments and public health officials are now predicting COVID-19 cases will continue to spike even higher in January following the Christmas and New Year’s holidays.

The most vocal advocate for stopping (or pausing) the men’s and women’s college basketball season is Duke’s basketball coach Mike Krzyzewski. Coach Krzyzewski wants the NCAA “…for the mental health and safety of our players and staff, to assess where we’re at” with with regards to the college basketball season and in light of more COVID-19 game cancellations.

The Duke men’s basketball program will forgo its remaining nonconference regular-season basketball games. The decision was made out of an abundance of caution due to the COVID-19 pandemic and to allow the Blue Devils’ players time over the holidays to spend with their families, according to a release from the university.

References:

  1. https://www.usatoday.com/story/sports/ncaab/acc/2020/12/09/mike-krzyzewski-wants-ncaa-re-evaluate-playing-during-covid-19/3864481001/
  2. https://www.usatoday.com/story/sports/ncaab/acc/2020/12/10/duke-cancels-remainder-nonconference-basketball-schedule/3889557001/
  3. https://www.usatoday.com/story/sports/christinebrennan/2020/12/09/college-basketball-while-covid-19-raging-makes-no-sense-coaches/3867975001/

Stopping the Exponential Rise in Cases

Posted on by

“Cases are rising. Hospitalizations are increasing, Deaths are increasing. We need to try to bend the curve, stop this exponential increase,” says Dr. Henry Walke, the CDC’s COVID-19 Incident Manager.

As COVID-19 cases continue to soar, it took the U.S. more than eight-and-a-half months to reach 8 million cases but less than two months to double that number.

As a result, hospitals across the U.S. are facing dire shortages of beds for critically ill coronavirus patients as the post-Thanksgiving holiday surge shows no sign of relenting, new data shows from the U.S. Department of Health and Human Services.

About 1 in 8 U.S. hospitals had little or no intensive care unit space available last week the data showed. And for the sixth consecutive day, the US reported a record high number of COVOD-19 patients in US hospitals: more than 108,000 nationwide, according to the Covid Tracking Project.

Public health experts say the number of hospitals struggling with intensive care unit capacity to accommodate the nation’s sickest patients likely will increase following another week of record COVID-19 cases.

As cases continue to soar, it took the U.S. more than eight-and-a-half months to reach 8 million cases but less than two months to double that number.

CDC and many states advise not to travel

As Americans contemplate whether to proceed with their holiday season or New Year’s travel plans, the U.S. Centers for Disease Control and Prevention (CDC) is urging citizens not to travel or to get tested before or is urging Americans who go against its advice to get tested for COVID-19 twice in a bid to make travel safer.

The agency says travelers should get a COVID-19 test one to three days before travel and three to five days after travel, regardless of their destination.

Additionally, some states are reimposing stay-at-home orders for their residents and travel restrictions ahead of the winter holidays.

While other states, such as Hawaii for example, require inbound travelers to show proof of a negative COVID-19 test upon arrival or require those without results before their arrival to quarantine for 14 days.

What to do

This is one time Americans should heed CDC urging to not to travel and stay home as the best way to protect yourself and others this year; or to get tested for COVID-19 twice in a bid to make travel safer.

References:

  1. https://www.jacksonville.com/story/travel/news/2020/12/11/holiday-travel-check-covid-19-travel-restrictions-by-state/3878341001/?
  2. https://www.jacksonville.com/story/news/coronavirus/2020/12/12/coronavirus-florida-what-you-need-know-saturday-dec-12/6511426002/?
  3. https://www.jacksonville.com/story/travel/airline-news/2020/12/09/covid-travel-test-things-to-know-coronavirus-testing-pcr-antigen/3800400001/?